In a study conducted in chemotherapy naive patients with NSCLC TAX326, 148 patients 36 in the TAXOTERE cisplatin group were 65 years of age or greater lasix for hypertension The IMPACT trial evaluated neoadjuvant therapy with A, T or C in postmenopausal women with estrogen receptor positive breast cancer